Immune infiltration analysis based on pyroptosis-related gene in metabolic dysfunction-associated fatty liver disease

被引:0
|
作者
Lian, Xin [1 ]
Tang, Xulei [1 ]
机构
[1] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Gansu, Peoples R China
关键词
Metabolic dysfunction-associated fatty liver; disease; Pyroptosis-related gene; Immune infiltration; Bioinformatics; NONALCOHOLIC STEATOHEPATITIS; EXPRESSION; PROTEIN; PATHOPHYSIOLOGY; INFLAMMASOMES; HEPATOCYTES; PROGRESSION; ACTIVATION; MECHANISMS; SIGNATURES;
D O I
10.1016/j.heliyon.2024.e34348
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a prevalent chronic disease that can involve pyroptosis. The primary objective of this study was to conduct a thorough and comprehensive analysis the pyroptosis-related genes in MAFLD. Methods: We identified pyroptosis-related differentially expressed genes (PRDEGs) in both healthy individuals and MAFLD patients. Using various bioinformatic approaches, we conducted an immune infiltration analysis from multiple perspectives. Results: A total of 20 pyroptosis-related LASSO genes were obtained, and 10 hub genes were used to do immune infiltration analysis. The hub genes were utilized in the construction of interaction networks between mRNA-miRNA and mRNA-TF. Immune characteristics analysis revealed multiple immune cell types significantly related to PRDEG expression, particularly genes HSP90AA1, TSLP, CDK9, and BRD4. Conclusion: Pyroptosis-related immune infiltration might be a mechanism of MAFLD progression and offers a research direction for potential treatment techniques.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] Use of a ferroptosis-related gene signature to construct diagnostic and prognostic models for assessing immune infiltration in metabolic dysfunction-associated fatty liver disease
    Lian, Xin
    Tang, Xulei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [2] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [3] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [4] The Pyroptosis-Related Gene Prognostic Index Associated with Tumor Immune Infiltration for Pancreatic Cancer
    Xie, Wen
    Li, Xiaoyi
    Yang, Chunxiu
    Li, Jiahao
    Shen, Guoyan
    Chen, Hongshan
    Xiao, Shu-Yuan
    Li, Yueying
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [5] LIVER FIBROSIS IN ASIANS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
    Kim, Byung Ik
    Sohn, Won
    Kwon, Heon-Ju
    Cho, Yong Kyun
    HEPATOLOGY, 2021, 74 : 1022A - 1022A
  • [6] Liver Fibrosis in Asians With Metabolic Dysfunction-Associated Fatty Liver Disease
    Sohn, Won
    Kwon, Heon-Ju
    Chang, Yoosoo
    Ryu, Seungho
    Cho, Yong Kyun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : E1135 - E1148
  • [7] Metabolic dysfunction-associated fatty liver disease: a year in review
    Alharthi, Jawaher
    Gastaldelli, Amalia
    Cua, Ian Homer
    Ghazinian, Hasmik
    Eslam, Mohammed
    CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (03) : 251 - 260
  • [8] Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
    Wen, Wen
    Li, Hong
    Wang, Chunyi
    Chen, Chen
    Tang, Jiake
    Zhou, Mengyun
    Hong, Xuwei
    Cheng, Yongran
    Wu, Qi
    Zhang, Xingwei
    Feng, Zhanhui
    Wang, Mingwei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [9] Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng, Gong
    Byrne, Christopher D.
    Targher, Giovanni
    Wang, Fudi
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2022, 42 (07) : 1496 - 1502
  • [10] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Bhopale, Kamlesh K.
    Srinivasan, Mukund P.
    LIVERS, 2023, 3 (04): : 597 - 617